Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 337–344 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Amgen Inc. ABP 959 - (SOLIRIS biosimilar) Paroxysmal nocturnal hemoglobinuria (PNH) Phase 3 Intravenous Hematology
Amgen Inc. Rocatinlimab (AMG 451/KHK4083) - (ROCKET/IGNITE) Moderate to severe atopic dermatitis (AD) Phase 3 Data Released Intravenous Immunology
Amgen Inc. KHK4083/AMG 451 - (ROCKET) Atopic dermatitis Phase 3 Intravenous Immunology
Amgen Inc. Tezepelumab - (WAYPOINT) Chronic Rhinosinusitis With Nasal Polyps Phase 3 Data Released Subcutaneous Respiratory
Amgen Inc. ABP 654 - (STELARA biosimilar) Plaque psoriasis Phase 3 Ongoing Subcutaneous Immunology: Anti-TNF
Amgen Inc. Tezepelumab Eosinophilic esophagitis (EoE) Phase 3 Ongoing Subcutaneous Gastroenterology
Amgen Inc. Rocatinlimab - (ASCEND) Moderate to severe atopic dermatitis (AD) Phase 3 Data Released Subcutaneous Immunology
Amgen Inc. ABP 654 - (STELARA biosimilar) Plaque psoriasis Phase 3 Ongoing Subcutaneous Immunology: Anti-TNF